NCT07545252

Brief Summary

This study is a prospective observational cohort study conducted planned to include 40 patients with ARDS to assess the effect of different levels of PEEP titration on VExUS score and renal outcomes in patients with Acute Respiratory Distress Syndrome.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Apr 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Apr 2026Oct 2026

Study Start

First participant enrolled

April 12, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2026

Expected
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2026

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

April 16, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

ARDSmechanically ventilatuonPEEP TitrationVExUS

Outcome Measures

Primary Outcomes (2)

  • VExUS score

    Change in VExUS score in relation to different PEEP levels in mechanically ventilated patients with ARDS.

    3 days

  • Development of acute kidney injury (AKI)

    Development of acute kidney injury (AKI), defined and staged according to the KDIGO criteria: increase in serum creatinine by ≥0.3 mg/dL within 48 hours, or ≥1.5 times baseline within 7 days, or urine output \<0.5 mL/kg/hour for 6 hours.

    3 days

Secondary Outcomes (3)

  • Requirement for renal replacement therapy (RRT) during ICU stay.

    3 days

  • Length of ICU stay

    4 to 7 days

  • ICU mortality

    4 to 7 days

Interventions

The Venous Excess Ultrasound Score (VExUS) was calculated for each patient based on the assessment of systemic venous congestion using the following parameters: Inferior vena cava (IVC) diameter and respiratory collapsibility, Hepatic vein Doppler waveform, Portal vein Doppler pulsatility and Intrarenal venous Doppler pattern.

Eligibility Criteria

Age18 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients with ARDS within 24 hours of onset and mechanically ventilated for more than 24 hours.

You may qualify if:

  • Age ≥18 years.
  • Diagnosis of ARDS according to the Berlin criteria.
  • Invasive mechanical ventilation ≥24 hours.
  • Requirement of PEEP ≥5 cmH₂O.

You may not qualify if:

  • Known end-stage renal disease on chronic dialysis.
  • History of renal transplantation.
  • Pregnancy.
  • Known severe tricuspid regurgitation.
  • Chronic liver disease with portal hypertension.
  • Poor ultrasound window precluding adequate venous Doppler assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Central Study Contacts

Hager R. Elsofey, MBBCh

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Critical Care Medicine

Study Record Dates

First Submitted

April 16, 2026

First Posted

April 22, 2026

Study Start

April 12, 2026

Primary Completion (Estimated)

September 20, 2026

Study Completion (Estimated)

October 12, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04